Pfizer withdrew its sickle cell disease treatment Oxbryta. Meanwhile, Senators introduce new bill to fortify health-care ...

A good chunk of your paycheck goes to medical insurance. Know your options. Prudent action and planning maximize every dollar ...

Pfizer will receive around £2.7 billion in aggregate from Haleon from an offering and a share buyback.

Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

An OPEC+ panel is unlikely this week to recommend any changes to its current deal to reduce production and to start unwinding ...

New data show excellent quality-of-life outcomes and effective tumor control for both intensity-modulated radiation therapy ...

With Tuesday’s announcement, Eastern North Carolina adds to its reputation for large-scale pharmaceutical manufacturing, as ...

Patients with chronic spontaneous urticaria improved early, with benefits lasting through the 52-week follow-up for those who ...

Pfizer anticipates revenue growth, driven by oncology investments, M&A activities, and manufacturing optimization. See why ...

No large pharma company has traversed this decade's ups and downs quite like Pfizer. | No large pharma company has traversed ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

Drugs giant struggling to manage slump in demand for Covid vaccines and antivirals as it falls behind rivals on obesity ...